at least four antibiotics, enabling studies of pathwayspecific and pleiotropic regulation of antibiotic production to be made. In addition, studies of the physiology and developmental biology (Hodgson, 1992 ;  Chater, 1993; Champness & Chater, 1994; Chater & Losick, 1996) of S. coeliculor are yielding information that will be essential for a thorough understanding of the interactions that occur between primary and secondary metabolism, and for elucidating the regulatory networks that influence both morphological differentiation and antibiotic production.
In addition to its fundamental interest, a thorough knowledge of how the complex antibiotic biosynthetic pathways are regulated will inevitably allow for the development of more rational approaches to strain improvement (Chater, 1990) . Although there is much to learn, this article summarizes work carried out in the author's laboratory that has contributed to our current understanding of the regulation of antibiotic production in S. coelicolor. Much of this information has arisen from the application of gene cloning to streptomycetes. This same technology has revealed some unusual features of gene expression in streptomycetes that will also be reviewed.
Antibiotic production in streptomycetes occurs in a growth-phasedependent manner
Antibiotic production in streptomycetes generally occurs in a growth-phase-dependent manner (Demain & Fang, 1995) . For example, production of the anti-fungal antibiotic candicidin in liquid-grown cultures of S. griseus occurs after vegetative growth, estimated by monitoring DNA synthesis, has ceased [ Fig. 1 , from Martin & McDaniel, 1975 ; note that biomass continues to increase after the onset of candicidin production, presumably through the accumulation of storage compounds such as glycogen (Brafia et al., 1986) or triacylglycerol (Olukoshi & Packter, 1994) l. Similarly, in the perhaps more natural conditions of agar surface-grown cultures of Streptomyes antibioticus, oleandomycin production again occurs only after vegetative growth has finished (Fig. 2, e t al., 1985) ; interestingly, synthesis of the antibiotic appears to be limited to the substrate mycelium, with production complete before the appearance of aerial hyphae.
A thorough understanding of how antibiotic production is regulated will require an integrated approach that combines genetics with biochemistry, physiology and molecular biology. The most genetically characterized and genetically manipulable streptomycete is S. coelicolor (Hopwood et a/., 1985a) . This organism has a welldeveloped genetic and physical linkage map (Kieser e t Redenbach etal., 1996) , and, in contradiction to the paradigm of Escherichia coli, possesses a linear, not circular, chromosome of approximately 8 Mb (Lin e t al., 1993) .
In addition, S. coeliculor possesses a number of accessory genetic elements, including at least two insertion sequences, IS I10 and IS I77 (Chater & Hopwood, 1993) . It contains SCP1, a large linear plasmid of 350 kb (Kinashi & Shimaji-Murayama, 1991 ) that carries genes for production of the cyclopentanone antibiotic methylenomycin (Kirby & Hopwood, 1977) (still the only proven example of plasmid-determined antibiotic biosynthesis), and an integrative element, SLPl, that normally resides in a stable form in the chromosome, but which is capable of excision, conjugation and autonomous replication in other streptomycetes (Bibb e t al., 1981 ; Omer & Cohen, 1984; Brasch & Cohen, 1993) . S. coeliculor also possesses a conventional circular plasmid, SCP2, which is selftransmissible and capable of mobilizing the chromosome (Bibb et al., 1977; Bibb & Hopwood, 1981) . Highfrequency transfer of the plasmid into a lawn of recipient bacteria that lack the element causes inhibition of growth and sporulation of the recipient lawn. The resulting 'pocks', which were shown to be a general property of Colworth Prize Lecture self-transmissible streptomycete plasmids, provided the plasmid-determined phenotype that was used to develop the transformation system that is currently used worldwide (Bibb et al., 1978) . This technique is based on the addition of DNA, in the presence of PEG1000, to protoplasts made by treating mycelium with lysozyme in an osmotically stabilizing medium.
Some unusual features of gene expression in streptomycetes
The availability of a transformation system, and of readily isolable streptomycete plasmids and phages, led to the rapid development of DNA cloning systems (Bibb e t al., 1980; Suarez & Chater, 1980; Thompson e t al., 1980; reviewed by Hopwood e t al., 1987) . The ability to clone streptomycete genes, and to examine their expression in vivo, revealed some of the basic features of gene expression in these organisms. It soon became apparent that streptomycetes possess a high degree of promoter sequence heterogeneity (Bibb e t al., 1985a; Janssen e t al., 1989; Janssen & Bibb, 1988 , 1990 Strohl, 1992) . Some of this variability reflects the occurrence of multiple 0 factors, which confer on RNA polymerase core enzyme the ability to recognize different subsets of promoter sequences (Westpheling etal., 1985; Buttner etal., 1988) . Thus far, at least eight different 0 factors have been identified in S. coelicolor (Buttner, 1989; Chater e t al., 1989; Lonetto e t al., 1994; Pottickovi e t al., 1995) , and presumably more remain to be discovered.
Many streptomycete genes were found to be transcribed from more than one promoter (Bibb etal., 1985b; Buttner e t al., 1987; Janssen & Bibb, 1988 , 1990 Janssen e t al., 1989; Strohl, 1992) , sometimes by more than one form of RNA polymerase holoenzyme (Buttner e t al., 1988 ; Westpheling & Brawner, 1989) . Although the significance of this for the regulation of gene expression is not known, it may reflect changes in the availability of 0 factors and other regulatory proteins during development. It also became apparent that a number of streptomycete mRNAs contravened the dogma of the time by lacking untranslated leader sequences (Janssen e t al., 1989; Bibb e t al., 1994; Strohl, 1992) . Instead, they commenced either at, or one nucleotide before, the translation start codon, and therefore lacked conventional ribosome-binding sites, which show a degree of complementarity to a sequence close to the end of 16s rRNA (Storm0 e t al., 1982) . For example, the primary transcripts for the neomycin resistance gene (aph) of Streptomyces fradiae (Janssen e t al., 1989) and for the erythromycin-resistance gene (ermE) of Saccharopobspora erythraea (formerly Streptomyces e rythraetls) (Bibb e t al., 1994) start at the first nucleotide of the ATG start codon and one nucleotide before the GTG start codon, respectively. Presumably, sequence information internal to such mRNAs is responsible for ribosome recognition. Although the reason for this unusual situation is not clear, the majority of leaderless transcripts found so far in streptomycetes are derived from antibioticresistance genes that confer immunity to an antibiotic made by the strain, and it may be that these leaderless mRNAs play an important role in the co-ordinate expression of antibiotic biosynthesis and resistance in the producing organism (Janssen, 1993) .
The advent of DNA cloning in streptomycetes inevitably led to the rapid accumulation of nucleotide sequence data for a variety of genes, confirming the predictable consequences of the high G + C content of streptomycete DNA on codon usage (Wright & Bibb, 1992) . With the G + C content of the third codon position averaging around 90 mol YO, streptomycete genes possess a highly biased codon usage. Consequently, a number of codons ending with A or U occur very infrequently, and at least one of these, the leucine codon UUA, may have acquired a regulatory function (see below). Although the high G + C content of streptomycete DNA can make sequence determination difficult, it does offer one compensationthe highly biased codon usage results in a predictable and distinct distribution of G + C content across codons. This characteristic feature formed the basis of a simple and reliable computer program for the localization of protein coding sequences and for the identification of frameshift errors that is also applicable to other organisms with high G + C DNA (Bibb e t al., 1984) .
Antibiotic biosynthetic genes occur in clusters that generally contain pathway-specif ic regulatory genes
It was not long before DNA cloning was applied to the study of antibiotic production. It was well-established that some streptomycetes made several different classes of antibiotics and that these compounds were generally the products of complex biosynthetic pathways. Although there was genetic evidence to indicate clustering of the biosynthetic genes, the ability to clone DNA in streptomycetes provided the first direct physical evidence for the extent of this clustering, and also served to identify the presence within these clusters of resistance determinants and pathway-specific regulatory genes.
This tight clustering was first demonstrated by cloning a 35 kb fragment of S. coelicolor DNA in Streptomjcesparvd~x that conferred production of the blue-pigmented polyketide antibiotic actinorhodin on its new host, which is not known to make any structurally related compounds (Malpartida & Hopwood, 1984) . These studies were followed shortly afterwards by the first example of the use of DNA cloning to produce a new antibiotic-introduction of the a c t V genes from S. coelicolor into a Streptomyes strain that produced medermycin resulted in the synthesis of a novel hybrid compound, mederrhodin (Hopwood e t al., 1985b) .
Gene cloning has since been used to study the regulation of antibiotic production, and it is this topic that is considered in the remainder of this article. Much of the following work, the aim of which is to decipher the physiological signals and underlying regulatory mechanisms that are responsible for the growth phasedependence of antibiotic production in S. coelicolor, was Fernindez-Moreno et al., 1992; Hobbs et al,, 1992 ; for reviews see Champness & Chater, 1994; Hopwood e t al., 1995; Chater & Bibb, 1996) . Many factors appear to influence the onset of antibiotic production in streptomycetes ( Fig. 3 ; Demain et al., 1983; Demain, 1992; Demain & Fang, 1995; Chater & Bibb, 1996) ; some of these are considered below.
Pathway-specific regulatory genes play a pivotal role in detemining the onset of antibiotic production in S. coelicolor
We have focused our attention on two of the four antibiotics made by S. coelimlor -the blue-pigmented polyketide actinorhodin (Act) and the chemically distinct red-pigmented tripyrolle undecylprodigiosin (Red). Under conditions of nitrogen limitation in liquid culture, Act and Red show classical production kinetics, with synthesis limited to stationary phase. By studying the regulation of both of these compounds, we can examine pathway-specific and pleiotropic regulation of antibiotic production. Many antibiotic-biosynthetic-gene clusters contain pathway-specific regulatory genes, most of which appear to act as transcriptional activators (Chater & Bibb, 1996) ; for the Act and Red pathways, the genes are actII-ORF4 (Fernindez-Moreno e t al., 1991) and redD (Narva & Feitelson, 1990) , respectively. Their products belong to an expanding family of regulatory proteins that includes the pathway-specific regulatory gene for daunorubicin production in Streptomyes peucetiw (Stutzman-Engwall e t al., 1992), and the putative pleiotropic regulatory gene a f~R (Horinouchi e t al., 1990) . ActII-ORF4 and RedD show 33% amino acid sequence identity, but as one would expect, they are unable to substitute for one another even when over-expressed, although ActII-ORF4 and DnrI apparently can (Stutzman-Engwall e t al., 1992) . In liquid culture, transcription of redD (Takano e t al., 1992) and of actII-ORF4 (Gramajo e t al., 1993) occurs only during transition and stationary phase, and is followed shortly afterwards by transcription of the corresponding biosynthetic structural genes. If expression of either pathway-specific regulatory gene is forced during exponential growth, premature transcription of the corresponding biosynthetic structural genes results, and antibiotic production occurs while rapid growth continues. Thus, the principal limitation to antibiotic production, at least in these defined laboratory conditions, appears to be the availability of enough of the pathway- 
Pleiotropic regulatory genes also control antibiotic production
In addition to pathway-specific regulatory genes, S. coelicolor possesses several genes with pleiotropic effects on antibiotic production. At least some of these are likely to play regulatory roles. The product of one, AfsR, is a homologue of ActII-ORF4 and RedD, with its N-terminal region showing 33 YO amino acid sequence identity to each of the pathway-specific regulatory proteins. afsR was first identified through its ability to stimulate Act production in Streptomyes lividans, a close relative of S. coelicolor in which the act and red genes are normally poorly expressed . Recent work identified a small gene (afsS) located immediately downstream of afsR that encodes a protein of 63 amino acids which alone is capable of stimulating antibiotic production (Matsumoto e t al., 1995; Vogtli e t al., 1994) . Re-examination of the earlier data does not contradict the hypothesis that afsS, and not afsR, is responsible for Act overproduction ; moreover, the reduction in Act production that followed disruption of afsR could have reflected a polar effect on afsS expression. So is afsR really a regulatory gene for antibiotic production ?
To address this question, high-copy-number plasmids that contained either afsR or afsS were made and both were shown to be capable of stimulating Act production in both S. coelicolor and S. lividans; however, the degree of stimulation mediated by afxR was significantly greater than that produced by afsS (Floriano & Bibb, 1996) . Since the N-terminal region of AfsR is homologous to ActII-ORF4 and RedD, this might simply reflect regulatory cross-talk between AfsR and the pathway-specific activators when AfsR is expressed at high levels. However, the inability of afsR to suppress in-frame deletion mutations in actII-ORF4 or redD even when cloned at high copy-number indicates that afsR cannot substitute for the pathway-specific regulatory genes. Consistent with this, a deletion in afsR that is in-frame and therefore unlikely to influence the expression of afsS results in the loss of Act and Red production on some media. Transcription of actII-ORF4 and redD was not affected by the a f R mutation (Floriano & Bibb, 1996) . So either AfsR influences Act and Red production independently of the pathway-specific regulatory proteins, or it is required for their activity, perhaps through their posttranslational modification, or through the formation of a heteromultimeric protein complex. However it mediates its effects, afsR is clearly a true pleiotropic regulatory gene.
A second pleiotropic regulatory gene for antibiotic production in S. coelicolor is afsB. afsB mutants are defective in Act and Red production (Hara e t al., 1983) , while synthesis of methylenomycin and the calcium-dependent antibiotic (CDA), the other two antibiotics known to be made by the strain, appears to be unaffected (Adamidis & Champness, 1992). Efforts to complement afsB using a genomic library made in a low-copy-number plasmid led to the interesting discovery that additional copies of hrdB, which encodes the major B factor of S. coeliculor (Brown e t al,, 1992), restored Red and Act production in afsB mutants (Wietzorrek, 1996) . The suppressive effect of hrdB resembles a recent report in Psezldopnonas fluarmens (Schnider e t al., 1995) , in which production of the antibiotics pyoluteorin and 2,4-diacetylphloroglucinol, which are made during stationary phase, was stimulated by the presence of additional copies of rpoD, which encodes the major and essential Q factor of that organism. Whether this reflects a role for the major B factor of both organisms in the transcription of antibiotic biosynthetic genes, or results from an indirect effect (e.g. provision of precursors), remains to be determined (see below).
The third pleiotropic regulatory gene for antibiotic production that has been studied in our laboratory is bldA (see Champness & Chater, 1994, and references therein).
On most laboratory media, bldA mutants have a very dramatic phenotype; not only are they deficient in aerial mycelium formation, giving rise to the term ' bald ', but they are also pleiotropically deficient in antibiotic production, failing to produce any of the four S. cooelidor antibiotics. bldA encodes the only tRNA in S. coelicolor that can efficiently translate the rare leucine codon UUA (Lawlor etal., 1987; Leskiw etal., 1991a) . The dependence of Act production on bldA was shown to be due to the presence of a single UUA codon in the actII-ORF4 transcript ; substitution of this codon on a plasmid-borne copy of actII-ORF4 with the synonymous leucine codon UUG rendered Act production bldA-independent (Fernindez-Moreno e t al., 1991). While control of transcription of bldA might seem to be a likely means by which to regulate growth-phase-dependent Act production, bldA transcripts are observed in minimal and rich liquid media throughout growth (Gramajo e t al., 1993) . Furthermore, we were unable to demonstrate any limitation on the translation of UUA codons in rapidly growing liquid cultures (Gramajo et al., 1993) . Thus, while Act production is clearly bldA-dependent, we have been unable to demonstrate any regulatory role for bldA. In contrast, in studies conducted largely, but not entirely, with surfacegrown cultures, Leskiw and colleagues did detect an increase in the level of bldA transcripts during growth, and limitations on the translation of UUA codons in young cultures (Leskiw e t al., 1991 (Leskiw e t al., b, 1993 ; the differences in the two sets of results may reflect differences in the strains and media used. The precise role that bldA plays in regulating antibiotic production therefore remains to be determined .
In contrast to actII-ORF4, the transcript derived from redD, the pathway-specific activator gene for Red production, does not contain a UUA codon (Narva & Feitelson, 1990) 
Small diffusible signalling molecules influence the onset of antibiotic production in S. coelicolor
Small diffusible signalling molecules play an important role in triggering antibiotic production in some streptomycetes (for reviews see Chater & Bibb, 1996 , and Horinouchi & Beppu, 1992 . For example, the ybutyrolactone A-factor is required for streptomycin production and sporulation in S. grisem (Khokhlov e t al., 1967; . S. coelicolor is capable of cross-feeding S. grisezls mutants that are deficient in Afactor synthesis (Hara e t al., 1983) , and makes a series of six related compounds (Anisova e t al., 1984 ; Efremenkova e t al., 1985) , but not A-factor itself. In an attempt to identify a role for these compounds in antibiotic production, we have purified a compound detectable only in transition-and stationary-phase cultures of S. coelicolor that causes the precocious production of both Act and Red in the wild-type strain. The compound was purified using standard procedures for the isolation of y-butyrolactones (E. Takano, personal communication), and it is likely that it is one of the six compounds identified by Efremenkova etal. (1985) . It thus appears probable that ybutyrolactones do indeed play a role in determining the onset of antibiotic production in S. coelicolor. Since the activity we detected was found only in transition-and stationary-phase cultures, it seems unlikely that these compounds act simply as quorum sensors, i.e. as indicators of cell density akin to the homoserine lactone derivatives made by Vibrio species (Fuqua e t al., 1994; Williams, 1994) . Similar observations were made for the accumulation of virginae butanolide C that stimulates virginamycin production in Streptomyes virginiae (Y ang e t al., 1995), and for A-factor production by S. grisezls (Hara & Beppu, 1982) . It thus appears more likely that the ybutyrolactones are produced in response to certain physiological or environmental signals.
The highly phosphoqylated nucleotide ppGpp may act as an intracellular effector for antibiotic production A consistent feature throughout the Streptoamzces literature is the likely role of a slowing or cessation of growth as a signal for determining the onset of antibiotic production.
In E. coli, the highly phosphorylated nucleotide ppGpp appears to play a central role in the growth rate control of gene expression (Sarubbi e t al., 1988; Hernandez & Bremer, 1990 Schreiber et al., 1991) , and in the regulation of at least some genes that are expressed in stationary phase (Gentry e t al., 1993) . Furthermore, relC mutants of a number of streptomycete strains that are defective in ppGpp synthesis are also impaired in antibiotic production, leading Ochi (1 990) to suggest that ppGpp may play a key role in determining the onset of antibiotic biosynthesis. In our own studies, we generally see a positive correlation between ppGpp synthesis and transcription of redD (Takano e t al., 1992) and actII-ORF4 (Strauch e t al., 1991) during transition and stationary phase of liquid-grown S. coelicolor cultures (Takano & Bibb, 1994) . Moreover, if an exponentially growing culture is subjected to nutritional shiftdown by rapidly depleting it of amino acids, large amounts of ppGpp are produced, and transcription of actII-ORF4 follows within minutes (Strauch e t al. ,1991). Unfortunately, relC mutants deficient in ribosomal protein L11, which is apparently required for activation of the ribosome-bound ppGpp synthetase, are also impaired in growth and so it is difficult to know whether or not the reduction in antibiotic production reflects reduced levels of ppGpp or impaired protein synthesis. To assess more rigorously whether there might be a causal relationship between ppGpp synthesis and antibiotic production, we used a PCR-based approach to clone the ppGpp synthetase gene (relA) of S. coelicolor (Chakraburtty et al., 1996) . The cloned gene was used to create a null-mutant that is totally deficient in ppGpp synthesis upon amino acid starvation (R. Chakraburtty, personal communication). The resulting mutant grows at the same rate as the relA+ strain; it fails to make Act or Red on some media, but does so on others. We believe that this indicates a crucial role for ppGpp in antibiotic biosynthesis under some nutritional conditions.
The role of t~ factor heterogeneity in antibiotic production in S. coelicolor Although S. coelicolor contains at least eight CJ factors (Buttner, 1989; Chater e t al., 1989; Lonetto e t al., 1994; Potuckovb e t al., 1995) Colworth Prize Lecture ability of the associated CJ factor might play a role in the regulation of antibiotic production. Analysis of RNA polymerase isolated from transition phase cultures of S. cueliculur indicated that both pathway-specific regulatory genes were transcribed by a holoenzyme that was different from the major form containing ahrdB (Fujii et al., 1996; Brown e t al., 1992) . Reconstitution experiments in which renatured components of the transition-phase holoenzyme preparations were added to S. cuelieulor and E. culi core RNA polymerase identified a protein of apparent molecular mass 46 kDa that would elicit in vitro transcription from redDp and actII-ORF4p (Fujii e t al., 1996) . Determination of the N-terminal amino acid sequence identified the protein as HrdD, a member of a family of four extremely similar proteins that includes the putative c factors ahrdA and ahrdC, and the major and essential CT factor, dLrdB (Buttner e t al., 1990 ; Brown e t a/., 1992;
Tanaka e t al., 1991). However, disruption of hrdD had no effect on Red and Act production (Buttner et al., 1990; Buttner & Lewis, 1992; Fujii et al., 1996) , indicating that redD and actII-ORF4 are transcribed in vivo by at least one other form of RNA polymerase holoenzyme. Circumstantial evidence su gests that this is the major holoperhaps reflect changing CT factor availability during growth and development.
enzyme containing $rdB . This apparent redundancy may
Summary
The work described above summarizes our attempts to understand the genetic regulation of antibiotic production in S. cuelieulor, and it should be apparent that there is much to learn. Nevertheless, we have characterized the expression of pathway-specific and pleiotropic regulatory genes, and we are beginning to understand the dependence relationships between them: but in no case do we know the molecular function of any of the gene products. We have isolated a diffusible factor, probably a y-butyrolactone, that clearly influences the onset of antibiotic production, and we believe that we have identified a role for ppGpp as an intracellular effector for antibiotic production, consistent with an important role for growth rate in determining the onset of antibiotic production: but in neither case is the signal transduction pathway identified, Other factors that appear to influence the onset of antibiotic production, and that have not been considered here, include nutritional repression and in- Bibb, 1996) . Some of these (the bld genes) are also required for morphological differentiation. Understanding the physiological and environmental conditions that trigger the expression of these genes, or that influence the activities of their products, and the corresponding signaltransduction pathways that are responsible for the activation of antibiotic biosynthesis remains a major goal for the future.
